Fralin Biomedical Research Institute at VTC | Virginia Tech Health & Biomedical Research
Featured Story
April 10, 2026
New lab removes barrier between research and patient care
Virginia Tech marked a step forward in biomedical innovation in Southwest Virginia with the opening a clean room facility to produce clinical-grade therapies under federally regulated Good Manufacturing Practice (GMP) standards.
The facility at the Fralin Biomedical Research Institute at VTC in Roanoke enables researchers and companies to manufacture clinical-grade materials that meet federal standards required for testing in human and animal patients.
Until now, that capability has been largely unavailable in the region, often forcing companies to look elsewhere to advance their work.
“The clean room facility is a critical step in translating discovery into real-world impact by enabling researchers to move promising therapies from the laboratory into early-stage manufacturing for patient use,” said Michael Friedlander, executive director of the Fralin Biomedical Research Institute at VTC and Virginia Tech vice president for health sciences and technology. “It grew out of real needs identified by academic researchers and companies in the region and reflects a collaborative effort to build the infrastructure required to support them.
Campus news
-
Home Item
Immune Recognition of Viruses and Cancer – A Five-decade Quest , homeApril 16, 2026, 5:30 p.m. (Reception at 5 p.m.) | Lewis Lanier, Ph.D., J. Michael Bishop Distinguished Professor and Chair Emeritus, Department of Microbiology and Immunology, University of California, San Francisco; Elected Member, National Academy of Sciences | Maury Strauss Distinguished Public Lecture
Creating a healthier future. For everyone.
The Fralin Biomedical Research Institute at VTC is one of the nation’s fastest-growing academic biomedical research enterprises and a destination for world-class biomedical, behavioral, and computational researchers focused on advancing scientific understanding of human health through groundbreaking research in preventing, diagnosing, and treating the world’s leading causes of death and suffering.
NEWS
In the News
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
VIDEOS
-
Home Item
Immune Recognition of Viruses and Cancer – A Five-decade Quest , homeApril 16, 2026, 5:30 p.m. (Reception at 5 p.m.) | Lewis Lanier, Ph.D., J. Michael Bishop Distinguished Professor and Chair Emeritus, Department of Microbiology and Immunology, University of California, San Francisco; Elected Member, National Academy of Sciences | Maury Strauss Distinguished Public Lecture
-
Home Item
Dissertation Defense: From Measurement to Policy: Sugar-sweetened Beverages as a Public Health Nutrition Target , homeApril 17, 2026, 10 a.m. | Haylee Downey | Graduate Student Dissertation Defense
-
Home Item
New Insights into Cardiac Mechanobiology: Role of Caveolar Nanodomains in Mechano-electrochemical Signal Transduction , homeApril 17, 2026, 11:00 a.m. | Alexey Glukhov, Ph.D., Associate Professor of Cardiovascular Medicine, UW-Madison Wisconsin Institutes for Medical Research, University of Wisconsin | Co-Sponsored by the Center for Vascular and Heart Research, Fralin Biomedical Research Institute
-
Home Item
Dissertation Defense: The Pulse of a Child’s Day: Understanding Sleep, Physical Activity, Nutrition, and Fatigue in Children with Developmental Disabilities , homeApril 21, 2026, 2 p.m. | Kavya Iyer | Graduate Student Dissertation Defense
-
Home Item
Dissertation Defense: Differential Expression of the Mitochondrial Calcium Uniporter (MCU) in Hippocampal Neurons Attunes Mitochondrial Calcium Handling and Bioenergetics , homeApril 22, 2026, 2 p.m. | Mikel L. Cawley | Graduate Student Dissertation Defense
-
Home Item
Special Seminar: Regulation of Targeted Therapies for Patients with Myeloid Malignancies , homeApril 23, 2026, 2 p.m., Cancer Research Center — D.C. | Kelly Norsworthy, M.D., Acting Director, Division of Hematologic Malignancies I, Office of Oncologic Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration | Special Seminar
Giving to the Research Institute
Your generous support of the Fralin Biomedical Research Institute's rigorous biomedical research enterprise makes a difference for our faculty, students, and patients. Every donation helps accelerate the pace of new discoveries to help patients with cancer, neurological disorders, heart disease, and even rare genetic disorders. Private donations fast-track our progress.